Abstract
Hydroxyapatite crystalline nanoparticles were created by a precipitation hydrothermal technique and the majority of crystal particles were in the size range of 40–60nm and exhibited a colloidal feature when suspended in water. The gastric cancer SGC-7901 cell line cells were cultivated in the presence of10–100 μg ml−1 hydroxyapatite nanoparticle suspension and verified by MTT evaluation for their biocompatibility in vitro. The agarose gel electrophoresis analysis demonstrated that the HA nanoparticles potentially adsorb the green fluorescence protein EGFP-N1 plasmid DNA at pH 2 and 7, but not at pH 12. The DNA–nanoparticle complexes transfected EGFP-N1 pDNA into SGC-7901 cells in vitro with the efficiency about 80% as referenced with Lipofectmine TM 2000. In vivo animal experiment revealed no acute toxic adverse effect 2weeks after tail vein injection into mice, and TEM examination demonstrated their biodistribution and expression within the cytoplasm and also a little in the nuclei of the liver, kidney and brain tissue cells. These results suggest that the HA nanoparticle is a promising material that can be used as gene carrier, vectors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berg K., M. B. Hansen & S. E. Nielsen, 1990. A new sensitive bioassay for precise quantification of interferon activity as measured via the mitochondrial dehydrogenase function in cells (MTT-method). APMIS 98 (2), 156–162.
Bloomfield V. A., 1996. DNA condensation. Curr. Opin. Struct. Biol. 6, 334–341.
Brown W. E. & L. C. Chow, 1987. A new calcium phosphate, water setting. J. Am. Ceramic Soc. 352–379.
Carsten K., S. Mohammad & G. H. Eleonore, 2000. Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA. Int. J. Pharmacol. 196, 257–261.
Chalfie M., 1994. Green fluorescent protein as a marker for gene expression. Science 263, 802–805.
Li Y. & X. Zhang, 2001. PEGylated PLGA nanoparticles as protein carriers synthesis, preparation and biodistribution in rats J. Control Release 71 (2), 203–211.
Martin R. B., M. W. Chapman, N. A. Sharkey, S. L. Zissimos, B. Bay, & E. C. Shors, 1993. Bone ingrowth and mechanical properties of coralline hydroxyapatite 1 yr after implantation. Biomaterials 14 (5), 341–348.
Mahan K. T. & M. J. Carey, 1999. Hydroxyapatite as a bone substitute. J. Am. Podiatr. Med. Assoc. 89 (8), 392–397.
Mosqueira V. C. F., P. Legrand & J. Morgat, 2001. Biodistribution of long-circulating PEG-grafted nanocapsules in mice effects of PEG chain length and density. Pharm. Res. 18, 1411–1419.
Rubanyi G. M., 2001. The future of human gene therapy. J. Mol. Aspects Med. 22 (3), 113–142.
Shirkhanzadeh M., 1991. Bioactive calcium phosphate coating prepared by electrodeposition. J. Mater. Sci. Lett. 10–1415.
Sugawara A., M. Nishiyama, L. C. Chow & S. Takagi, 1990. A new biocompatible material calcium phosphate. biomedical applications. Tokyo Shika Ishikai Zashi 38, 348–354.
Yu D., J. Wong & Y. Matsuda, 1992. Self-setting hydroxyapatites:A novel skeletal drug-delivery system for antibiotics. J. Pharm. Sc. 81 (6), 529–561.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhu, S., Huang, B., Zhou, K. et al. Hydroxyapatite Nanoparticles as a Novel Gene Carrier. J Nanopart Res 6, 307–311 (2004). https://doi.org/10.1023/B:NANO.0000034721.06473.23
Issue Date:
DOI: https://doi.org/10.1023/B:NANO.0000034721.06473.23